PD 117519
|
|
PD 117519 Eigenschaften
- storage temp.
- 2-8°C
- L?slichkeit
- DMF: 10mg/mL; DMF:PBS (pH 7.2) (1:4): 0.2mg/mL; DMSO: 5mg/mL; Ethanol: 0.1mg/mL
- Aggregatzustand
- A solid
- Farbe
- White to off-white
- InChIKey
- FSKMJUWPFLDDRS-BYMDKACISA-N
- SMILES
- OC[C@H]1O[C@@H](N2C3C(=C(N=CN=3)N[C@H]3C4=C(C=CC=C4)CC3)N=C2)[C@H](O)[C@@H]1O
Sicherheit
PD 117519 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
N6-Substituted adenosine receptor agonist; a potential antihypertensive agent.in vitro
PD 117519 (2-10 mg/kg; oral administration; 16-24 hours; male beagle dogs) treatment produces significant hemodynamic changes at Tmax (4 hours) follows by acute coronary vascular injury that is evident at 16 hours postdosing.Treatment with 2 or 10 mg/kg of PD 117519 produces significant increases in mean heart rate and decreases in mean indirectsystolic blood pressure at time of highest drug exposure, 4 hours postdosing.PD 117519 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
PD 117519 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 63)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
PANNACEAN(HENAN)MEDICINE SCIENCE TECHNOLOGIES LTD | 0371-55159968 18137130222 |
haifeng.zhang@pannacean.com | China | 645 | 58 |
Shenzhen Nexconn Pharmatechs Ltd | +86-755-89396905 +86-15013857715 |
admin@nexconn.com | China | 10311 | 58 |
SHANGHAI T&W PHARMACEUTICAL CO., LTD. | +86-021-61551413 +8618813727289 |
contact@trustwe.com | China | 5738 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 32161 | 58 |
Career Henan Chemica Co | +86-0371-86658258 +8613203830695 |
laboratory@coreychem.com | China | 30236 | 58 |
BOC Sciences | 16314854226; +16314854226 |
inquiry@bocsci.com | United States | 19741 | 58 |
NewCan Biotech Limited | +86-0571-86912261 +8613735419629 |
sales@newcanbio.com | China | 9982 | 58 |
LEAP CHEM CO., LTD. | +86-852-30606658 |
market18@leapchem.com | China | 24727 | 58 |
TargetMol Chemicals Inc. | |
support@targetmol.com | United States | 38631 | 58 |
Aladdin Scientific | +1-+1(833)-552-7181 |
sales@aladdinsci.com | United States | 57505 | 58 |
- (R)-N-(2,3-Dihydro-1H-indenyl)adenosine
- N-[(1R)-Indan-1-yl]adenosine
- N-[[(R)-2,3-Dihydro-1H-inden]-1α-yl]adenosine
- CI 947
- N-[(1R)-2,3-Dihydro-1H-inden-1-yl]adenosine
- PD 117519
- N-[(R)-Indan-1-yl]adenosine
- Adenosine, N-[(1R)-2,3-dihydro-1H-inden-1-yl]-
- PD 117519,R
- PD 11751
- PD-117519;PD 117519;PD117519;CI 947;CI947
- N-[(R)-Indan-1-yl] adenosine, Drug, N-substituted adenosine receptor agonist, a potential antihypertensive agent
- N-[(R)-Indan-1-yl]adenosine, PD-117519, CI947
- CI-947,PD-117519,Adenosine Receptor,Inhibitor,P1 receptor,PD117519,PD 117519,inhibit,CI 947
- PD 117519 (CI947)
- (2R,3R,4S,5R)-2-(6-(((R)-2,3-Dihydro-1H-inden-1-yl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
- PD 117519, 10 mM in DMSO
- 96392-15-3
- Bases & Related Reagents
- Carbohydrates & Derivatives
- Intermediates & Fine Chemicals
- Nucleotides
- Pharmaceuticals